Fig. 2From: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment optionsLuminal (a) to triple negative (n = 18) vs. triple negative concordant (n = 46). A 10 year overall survival (p = 0.064). b 5 year post-recurrence survival (p < 0.05)Back to article page